Skip to main content
CAI logo

CAI · Caris Life Sciences, Inc. · Proposed Sales

Track CAI — free
$17.58 -0.96 (-5.18%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$5.04B
Shares
286.78M
Volume · Nov 20 4.57M Avg daily vol (3M) 4.64M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-09-22 JOHN RUSSEL DENTON 7,500
2026-09-17 BRIAN J BRILLE 400,000
2026-09-04 DAVID SPETZLER 119,212
2026-09-03 DAVID SPETZLER 478,000
2026-08-24 GEORGE H POSTE REVOCABLE TRUST 100,000
2026-08-07 GEORGE H POSTE 30,000
2026-08-03 GEORGE H POSTE 20,000
2025-12-11 LUKE POWER 62,250
Showing 1–8 of 8 filings
Key facts CIK 2019410 CUSIP 142152107 13F (30d) 312 filings 296 filers Visit website Investor relations